Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04264806
Title A Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are Not Candidates for Hematopoietic Stem Cell Transplantation (HSCT)
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Janssen Research & Development, LLC

chronic myelomonocytic leukemia

myelodysplastic syndrome


ARGX-110 + Azacitidine


Age Groups: adult | senior
Covered Countries ITA | FRA | ESP | DEU

No variant requirements are available.